Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03657212 · ClinicalTrials.gov registry record · Phase 4
Enhancing Memory Consolidation in Older Adults
A Phase 4 study, sponsored by University of California, Irvine.
- Terminated
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
NCT03657212 is a Phase 4 study that was terminated before completion, run by University of California, Irvine. The registered enrollment target is 10 participants.
The verdict
NCT03657212, a Phase 4 study, was terminated before completion, sponsored by University of California, Irvine.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this research study is to understand the neural mechanisms underlying long-term memory formation in older adults. Both sleep and memory decrease with age. The investigators are interested in discovering whether these two biological changes are related. This study is specifically focused on understanding what are the critical components of sleep that facilitate memory formation and are they impaired in older adults. The investigators will be using the hypnotic zolpidem, a sleep drug that has been shown to increase a specific aspect of sleep that have been shown to correlate with memory improvement in young adults. The Food and Drug Administration (FDA) have approved zolpidem for use in certain sleep disorders, specifically in the treatment of sleeplessness (i.e., insomnia). In the current study, the investigators will examine whether zolpidem (5mg), compared with placebo, increases memory-related sleep events in older adults and test the impact of these drug-related sleep changes on post-sleep memory recall. This is a research study because the investigators are using pharmacological interventions to investigate our hypotheses about memory consolidation. The investigators are not studying the efficacy of zolpidem to treat conditions for which the FDA has already approved it.
Interventions
- DRUG Zolpidem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-10-01 |
| Est. Completion | 2019-01-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03657212
The ClinicalTrials.gov registry entry for NCT03657212 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Zolpidem is the first listed.
NCT03657212 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03657212 about?
NCT03657212 is a clinical study titled "Enhancing Memory Consolidation in Older Adults". The purpose of this research study is to understand the neural mechanisms underlying long-term memory formation in older adults. Both sleep and memory decrease with age. The investigators are interested in discovering whether these two biological changes are related. This study is specifically focus...
What is the current status of trial NCT03657212?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2018-10-01. Estimated completion is 2019-01-01.
What interventions are being tested in trial NCT03657212?
The interventions under investigation include: Zolpidem (DRUG).
Who is sponsoring clinical trial NCT03657212?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.